| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | zf-C2H2 | 7.03e-04 | 693 | 41 | 7 | PF00096 | |
| Domain | SH3 | 1.26e-03 | 216 | 41 | 4 | PS50002 | |
| Domain | SH3_domain | 1.35e-03 | 220 | 41 | 4 | IPR001452 | |
| Domain | ZINC_FINGER_C2H2_2 | 1.35e-03 | 775 | 41 | 7 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 1.37e-03 | 777 | 41 | 7 | PS00028 | |
| Domain | Znf_C2H2-like | 1.58e-03 | 796 | 41 | 7 | IPR015880 | |
| Domain | Znf_C2H2 | 1.68e-03 | 805 | 41 | 7 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.72e-03 | 808 | 41 | 7 | SM00355 | |
| Domain | PID | 2.24e-03 | 32 | 41 | 2 | PS01179 | |
| Domain | - | 3.43e-03 | 679 | 41 | 6 | 3.30.160.60 | |
| Domain | PTB | 3.48e-03 | 40 | 41 | 2 | SM00462 | |
| Domain | PTB/PI_dom | 3.65e-03 | 41 | 41 | 2 | IPR006020 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 3.82e-03 | 694 | 41 | 6 | IPR013087 | |
| Domain | SH3_1 | 5.55e-03 | 164 | 41 | 3 | PF00018 | |
| Pubmed | 9.16e-06 | 418 | 41 | 6 | 34709266 | ||
| Pubmed | Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias. | 7.41e-05 | 11 | 41 | 2 | 8563752 | |
| Pubmed | 1.07e-04 | 650 | 41 | 6 | 38777146 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.14e-04 | 212 | 41 | 4 | 33853758 | |
| Pubmed | 1.20e-04 | 215 | 41 | 4 | 35973513 | ||
| Pubmed | 1.21e-04 | 963 | 41 | 7 | 28671696 | ||
| Pubmed | 2.06e-04 | 733 | 41 | 6 | 34672954 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 2.47e-04 | 1082 | 41 | 7 | 38697112 | |
| Pubmed | 2.82e-04 | 777 | 41 | 6 | 35844135 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 2.99e-04 | 1489 | 41 | 8 | 28611215 | |
| Pubmed | 3.48e-04 | 284 | 41 | 4 | 29459677 | ||
| Pubmed | Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC. | 3.91e-04 | 293 | 41 | 4 | 31741433 | |
| Pubmed | 4.51e-04 | 549 | 41 | 5 | 38280479 | ||
| Pubmed | 4.69e-04 | 128 | 41 | 3 | 23858473 | ||
| Pubmed | 4.90e-04 | 130 | 41 | 3 | 12421765 | ||
| Pubmed | 6.91e-04 | 1285 | 41 | 7 | 35914814 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 7.44e-04 | 934 | 41 | 6 | 33916271 | |
| Pubmed | α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration. | 7.87e-04 | 35 | 41 | 2 | 37381005 | |
| Pubmed | 7.87e-04 | 35 | 41 | 2 | 23291589 | ||
| Pubmed | 7.87e-04 | 35 | 41 | 2 | 33864728 | ||
| Pubmed | 8.80e-04 | 37 | 41 | 2 | 32912968 | ||
| Pubmed | 9.28e-04 | 38 | 41 | 2 | 33283408 | ||
| Pubmed | Parcellation of the striatal complex into dorsal and ventral districts. | 1.13e-03 | 42 | 41 | 2 | 32170006 | |
| Cytoband | 8p21 | 1.46e-04 | 20 | 41 | 2 | 8p21 | |
| Cytoband | 16p12.2 | 5.08e-04 | 37 | 41 | 2 | 16p12.2 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.73e-04 | 718 | 31 | 7 | 28 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.73e-05 | 212 | 40 | 5 | M39221 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.20e-07 | 184 | 41 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 7.20e-07 | 184 | 41 | 5 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.20e-07 | 184 | 41 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.40e-07 | 185 | 41 | 5 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.80e-07 | 187 | 41 | 5 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 8.22e-07 | 189 | 41 | 5 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.44e-07 | 190 | 41 | 5 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.59e-07 | 195 | 41 | 5 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-06 | 197 | 41 | 5 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.37e-05 | 159 | 41 | 4 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.96e-05 | 174 | 41 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.19e-05 | 179 | 41 | 4 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 2.49e-05 | 185 | 41 | 4 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 2.54e-05 | 186 | 41 | 4 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.59e-05 | 187 | 41 | 4 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Control-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 2.59e-05 | 187 | 41 | 4 | 3a032432f780525f4f4c2a358897d9989b1ecae7 | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 2.59e-05 | 187 | 41 | 4 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | COPD-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 2.71e-05 | 189 | 41 | 4 | 14e8e57e4db336fbef005270647983b4edf407c0 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-05 | 194 | 41 | 4 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.00e-05 | 194 | 41 | 4 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | BL-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.00e-05 | 194 | 41 | 4 | 2932f704656ca368565ec12f3452af3b18e8df12 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-05 | 194 | 41 | 4 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-05 | 195 | 41 | 4 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-05 | 195 | 41 | 4 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-05 | 195 | 41 | 4 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-05 | 197 | 41 | 4 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.18e-05 | 197 | 41 | 4 | a4855c5aebea4f0fed4eb035844572e82e5bac46 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.18e-05 | 197 | 41 | 4 | 61c1c29a62d4c033999b7f0183c1e9cdd6a62925 | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.18e-05 | 197 | 41 | 4 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 3.31e-05 | 199 | 41 | 4 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.17e-04 | 103 | 41 | 3 | 780a94c27ac3eb138a9f284251ae094d3e97ce71 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 119 | 41 | 3 | aa3860c8d25c85baa79a0b6637bce2e269adfcc2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-04 | 138 | 41 | 3 | 2e46d546ad962aa0fde5b1c18c2a5370a4424e9f | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.07e-04 | 143 | 41 | 3 | cc396b81a5e47d78c2d1cb49d682391376b63476 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-04 | 144 | 41 | 3 | 163c591fedad2beb7f92531e6240e9554f90ea40 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_P4HA3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.34e-04 | 161 | 41 | 3 | 0d05aa57312b095752fe13333b2def5f5b1cc83e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.42e-04 | 162 | 41 | 3 | 6ffcf369d954c20ce036aa1d072cee4e205f728e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.42e-04 | 162 | 41 | 3 | bcbf7f80a2a1c80def795e345f16cf16e8b9d03b | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 164 | 41 | 3 | 07d9252b267cb61c6050fbfa5b440aef1349f673 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 164 | 41 | 3 | 7c016236f0cea38195c1373ebbd2c0b2b2ec81ad | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-04 | 165 | 41 | 3 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-04 | 165 | 41 | 3 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 168 | 41 | 3 | 04a7810f95196a21325356b42084f96c11af5964 | |
| ToppCell | Tuft-tuft-1|World / Class top | 4.91e-04 | 168 | 41 | 3 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.91e-04 | 168 | 41 | 3 | d03e91f0e0518b33555c0ec98124fc5ed0f11be5 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Macrophage|GI_small-bowel / Manually curated celltypes from each tissue | 4.91e-04 | 168 | 41 | 3 | d5b746d6083c2c8155a0ea345ea368bf6617d5ca | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.91e-04 | 168 | 41 | 3 | 59b698f58cb206f0f8f0e8ad72b445d14ba24728 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-04 | 169 | 41 | 3 | 7c994653b0d629dfb046755d6b678452de0a15d2 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-04 | 169 | 41 | 3 | da3485d77bb7876fad4f166f6099e681b27457ae | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-DC1|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.00e-04 | 169 | 41 | 3 | 488ba50631a64cb9e0d69219491c66ac824c9e7d | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 5.08e-04 | 170 | 41 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.08e-04 | 170 | 41 | 3 | 6c65ddb496030bb479ef346cc37a9d4dfa6b824f | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 5.08e-04 | 170 | 41 | 3 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 5.26e-04 | 172 | 41 | 3 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | Leuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, Lineage and Cell Type | 5.35e-04 | 173 | 41 | 3 | 226bb8d881f32d65c60f5e4c034c6d465f8e7ba5 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 173 | 41 | 3 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 173 | 41 | 3 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 5.35e-04 | 173 | 41 | 3 | 62e0c18cfed9645e34a9d7029c94a8554f773714 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-CLP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-04 | 173 | 41 | 3 | b367b62309389e8b6a65de83c2434dc8ec905985 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 173 | 41 | 3 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.35e-04 | 173 | 41 | 3 | 5c55e1e27e9e3e77600d378cc87b51cc73907527 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 5.44e-04 | 174 | 41 | 3 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | mild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.53e-04 | 175 | 41 | 3 | b87f279a7519710146c49d6acccb0adedc195965 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-04 | 175 | 41 | 3 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | mild-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.62e-04 | 176 | 41 | 3 | 59a9c262c252b7d220a025837922d98e9d6b0a24 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.62e-04 | 176 | 41 | 3 | c7be4eaa5eb76ad9389fb9d15ad0934e88d267d1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.62e-04 | 176 | 41 | 3 | 07abf29d681abdd6c7cc87f9eaf9377e92ce212c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.62e-04 | 176 | 41 | 3 | 5f8c1f917fba49f3b1c0d88b946eca242b668fde | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.72e-04 | 177 | 41 | 3 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.72e-04 | 177 | 41 | 3 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.72e-04 | 177 | 41 | 3 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-04 | 177 | 41 | 3 | 8b003ed7887479c3a010ef37dd981b748256bda7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.81e-04 | 178 | 41 | 3 | 5d6297f34e104bacefb25c4e2338b50fe13dd19a | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.81e-04 | 178 | 41 | 3 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-04 | 179 | 41 | 3 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | CD8+_Memory_T_cell-FLU-5|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 5.91e-04 | 179 | 41 | 3 | 7f18dffa85285599662edbcd3f32ab42672bffb8 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.91e-04 | 179 | 41 | 3 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.00e-04 | 180 | 41 | 3 | 0b653b1b653b40f3b8711d1312029a4a8a4961db | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.00e-04 | 180 | 41 | 3 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.00e-04 | 180 | 41 | 3 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.00e-04 | 180 | 41 | 3 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.00e-04 | 180 | 41 | 3 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-04 | 181 | 41 | 3 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-04 | 181 | 41 | 3 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.10e-04 | 181 | 41 | 3 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-04 | 181 | 41 | 3 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.10e-04 | 181 | 41 | 3 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-04 | 181 | 41 | 3 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | d41ff834b8fc1d0e23cac7ae261de5f72874e462 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | 6cde859edfe7607bd7ada89d20258413d06f4207 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.20e-04 | 182 | 41 | 3 | ea39b1b5db185b0cb11dfa2e01f3f972effbd770 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.20e-04 | 182 | 41 | 3 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.20e-04 | 182 | 41 | 3 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.20e-04 | 182 | 41 | 3 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 6.30e-04 | 183 | 41 | 3 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| Drug | magnesium acetate tetrahydrate | 5.61e-06 | 20 | 40 | 3 | CID000134717 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 1.46e-04 | 13 | 41 | 2 | C1846647 | |
| Disease | Nonsyndromic Deafness | 1.97e-04 | 81 | 41 | 3 | C3711374 | |
| Disease | autism spectrum disorder (is_implicated_in) | 2.23e-04 | 16 | 41 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | lipoprotein measurement | 4.23e-04 | 105 | 41 | 3 | EFO_0004732 | |
| Disease | bowel opening frequency | 7.99e-04 | 30 | 41 | 2 | EFO_0600084 | |
| Disease | posterior thigh muscle fat infiltration measurement | 1.09e-03 | 35 | 41 | 2 | EFO_0020934 | |
| Disease | hip circumference | 1.23e-03 | 338 | 41 | 4 | EFO_0005093 | |
| Disease | response to risperidone | 1.28e-03 | 38 | 41 | 2 | GO_0097336 | |
| Disease | alcohol consumption measurement | 1.48e-03 | 1242 | 41 | 7 | EFO_0007878 | |
| Disease | body weight | 1.61e-03 | 1261 | 41 | 7 | EFO_0004338 | |
| Disease | low density lipoprotein particle size measurement | 2.96e-03 | 58 | 41 | 2 | EFO_0008593 | |
| Disease | diet measurement | 3.09e-03 | 1049 | 41 | 6 | EFO_0008111 | |
| Disease | polychlorinated biphenyls measurement | 3.71e-03 | 65 | 41 | 2 | EFO_0007042 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.72e-03 | 224 | 41 | 3 | EFO_0004530, EFO_0008317 | |
| Disease | radiation-induced disorder | 3.93e-03 | 67 | 41 | 2 | EFO_0009565 | |
| Disease | body fat percentage | 4.61e-03 | 488 | 41 | 4 | EFO_0007800 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HTHSVFMSSNVTVFQ | 16 | Q6ZS92 | |
| HINHNTSEKSLNFSM | 246 | Q8IZF3 | |
| QEKQHTTTNVFHFTF | 381 | Q9Y305 | |
| QHDEKMTTFFSHNFN | 1686 | Q8TDJ6 | |
| GFTNMAHVTQAHVQT | 956 | Q8WWM7 | |
| TALVFHSNQHMNTVD | 171 | Q6ZSG2 | |
| SIVSSLDFHRMNHNQ | 531 | Q7Z6G8 | |
| NFNMRNTSTIHRQAH | 316 | Q7RTW8 | |
| NYQFMSSHIKSVHSQ | 561 | Q86T24 | |
| ASSHQFQQMSRDFQA | 4846 | Q03001 | |
| SFSASQNTMQSHIIF | 2666 | O43451 | |
| VLSSMQHFSEAFHQV | 551 | Q9H165 | |
| TRQQMLHAQTFHSNS | 316 | Q32NB8 | |
| NSNVIMHETSQYHVQ | 41 | Q9H6S3 | |
| MNSTLFSQVENHSVH | 1 | P25929 | |
| VSQSNMSAFSQVFSH | 306 | Q58A45 | |
| QMVFHLETNSNSESH | 196 | Q5U623 | |
| MSSINNTLSNHQLTH | 951 | Q9P267 | |
| FTTQHALHQAQMSKE | 511 | Q2VIQ3 | |
| KFSAMHEFQNLHAQS | 286 | P13807 | |
| FTNINATDNHVHSML | 361 | Q6AZY7 | |
| QTLSNMVSQAQSHHE | 1681 | Q12923 | |
| MLHTNNTQFHPSTFL | 1 | Q8NH55 | |
| VLHNIEQHSSSNQMT | 491 | Q9P2F6 | |
| QHATLQVFTQFHTTS | 591 | Q6IEE7 | |
| EQSHLHMSSETQANN | 156 | Q15054 | |
| QLNMSHQFSHFNVLT | 1601 | Q9UK61 | |
| ALHNMVQFSHSKDFQ | 266 | Q9UHF7 | |
| FFQTELQNHTMTQHS | 1296 | Q96K83 | |
| VTHVFHVQQTEMSQT | 26 | Q9H106 | |
| FHMSQQTEIPAHQQT | 21 | Q6PF05 | |
| IFEHTSMANSFNTHF | 286 | O95859 | |
| NIGQMLRTHFTHSQF | 1126 | O95347 | |
| HHLFTTTINLNSMND | 766 | Q07157 | |
| VQFMLNNHTSEHFSF | 636 | Q9UIA9 | |
| SQQHLSANMFVALHS | 376 | Q8TEC5 | |
| AFSQSMNLTVHQRTH | 166 | Q6ZN57 | |
| FSQTSNFTQHQRIHT | 356 | O75123 | |
| TFSHSTALFVHMQTQ | 221 | Q9BR84 | |
| TQTSHVFHGQENMFL | 16 | A6NCI4 | |
| TAFSHSNTMSIHSQQ | 5006 | Q9UKN1 | |
| QVMNTHFNSLHIVNT | 391 | Q96S06 |